Temozolomide is a chemotherapeutic medication used to treat anaplastic oligodendroglioma, anaplastic astrocytoma, glioblastoma multiforme, and melanoma, among other brain tumors. Temozolomide inhibits the growth of cancer cells, which the body eventually eliminates. Other adverse effects may arise because temozolomide may disrupt the growth of normal body cells. It's available in tablet and capsule form, as well as an injectable solution, according to suppliers. Merck Sharp & Dohme, the temozolomide manufacturer, and supplier, introduced the drug in 1999 and maintains the market leader for temozolomide. Other prominent temozolomide suppliers, including Novartis, Accord Healthcare, Teva, Mylan, and Sun Pharmaceutical Industries, have recently entered the market with their generic and trade name versions. Temozolomide may cause some side effects like nausea, sickness, loss of appetite, sore throat, changes in taste, dysentery, fatigue, disorientation, difficulty sleeping, or headache are all possible side effects. Nausea and vomiting can be quite unpleasant. Some of these effects can be mitigated by eating multiple small meals throughout the day, not eating before treatment, or restricting activity. You may experience temporary hair loss. After the procedure, normal hair growth should resume. Even though temozolomide is used to treat cancer, it has a small chance of increasing your risk of developing other malignancies. Temozolomide also inhibits bone marrow activity, which may result in a reduction in the number of blood cells such as red cells, white cells, and platelets. This consequence can result in anemia, a reduction in your body's ability to fight infection, or easy bruising and bleeding. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking TEMOZOLOMIDE: You should not use This medical remedy if you are allergic to it This drug may also be used for purposes that may not have been listed in this medication guide.

TEMOZOLOMIDE hinders the creation of cholesterol by blocking the site of the enzyme that is the origin of cholesterol production. Thus, resulting in reduced levels of LDL in the blood. This pharmaceutical substance is the aggressive and most common adult primary brain tumor, accounting for 45.6% of all primary malignant brain tumors. Originally defined histopathologically by microvascular and necrosis generation, this medical remedy is commonly prescribed through radiotherapy and concomitant alkylation-based chemotherapy with temozolomide.9 Temozolomide (TMZ) is a small (194 Da) lipophilic alkylating agent of the imidazotetrazine belongs to the category that is stable at acidic pH, allowing for both intravenous and oral dosing, and can cross the blood-brain barrier to affect CNS tumors.

Read the TEMOZOLOMIDE Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking TEMOZOLOMIDE. If you have any questions related to TEMOZOLOMIDE, ask your pharmacist or doctor. Use this medication regularly to get the most benefit from it. Keep taking this medication even if you feel well. Tell your doctor if you do not get better or if you get worse (for example, your blood pressure readings remain high or increase).

Temozolomide is commonly sold in five-tablet containers with strengths of 20 mg, 100 mg, and 140 mg. 17.58 – 21.10 USD, 93.86 – 117.21 USD, and 128.93 – 164.09 USD are the approximate retail price ranges for each.

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of TEMOZOLOMIDE offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for TEMOZOLOMIDE manufacturers and TEMOZOLOMIDE suppliers that you are looking for. These also enable you to check the dossier status of TEMOZOLOMIDE, and the GMP approvals of the different variants of TEMOZOLOMIDE. Also, each manufacturer or supplier product description contains essential information about TEMOZOLOMIDE including clinical data, stability zones, countries where TEMOZOLOMIDE is already registered in. Manufacturers also have special, and delivery terms.

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are onboarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.